Sat Kartar Life Limited Receives NSE In-Principle Approval for Equity Share Issuance via Warrant Conversion

Sat Kartar Life Limited (formerly known as Sat Kartar Shopping Limited) has received in-principle approval from the National Stock Exchange of India Limited (NSE) for the issuance of equity shares pursuant to the conversion of warrants through a preferential issue. The approval was communicated vide NSE letter bearing Ref. No. NSE/LIST/54702 dated May 08, 2026, under Regulation 28(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company had submitted its application to NSE on April 21, 2026, seeking this approval.

Details of the Approved Share Issuance

The in-principle approval covers two tranches of equity shares to be allotted upon conversion of warrants issued through a preferential issue. The key details of the approved issuance are as follows:

Parameter: Details Approval Reference: NSE/LIST/54702 Approval Date: May 08, 2026 Tranche 1 – Equity Shares: 50,400 shares of Rs. 10/- each Tranche 2 – Equity Shares: 27,74,400 shares of Rs. 10/- each Face Value: Rs. 10/- per share Mode of Issuance: Conversion of warrants via preferential issue Regulatory Framework: Regulation 28(1) of SEBI (LODR) Regulations, 2015

Conditions Attached to the Approval

The NSE has granted the in-principle approval subject to the company fulfilling a set of regulatory and procedural conditions. These conditions must be met before the final listing of the shares is permitted.

Filing the listing application at the earliest from the date of allotment

Receipt of statutory and other approvals, and compliance with guidelines and regulations issued by statutory authorities including SEBI, RBI, and MCA

Compliance with all applicable guidelines, regulations, and directions of the Exchange or any statutory authorities as on the date of the listing application

Compliance with all conditions as per the SEBI (LODR) Regulations, 2015, Companies Act, 1956/Companies Act, 2013, and other applicable laws

Submission of documents as may be required by NSE and payment of applicable fees

Internal Controls and Allottee Compliance Advisory

The NSE has also advised the company to strengthen internal controls to monitor trades executed by the proposed allottees in the company's scrip prior to allotment. Specifically, the exchange has directed the company to obtain an undertaking from the allottee(s) confirming that they shall not engage in intra-day trading or any sale in the company's scrip until the allotment date, as required under SEBI (ICDR) Regulations. The responsibility and onus to verify and ensure such compliance, including adherence to Regulation 167(6) of SEBI ICDR Regulations, 2018, rests solely with the issuer company. The NSE has further noted that any non-compliances observed post the undertaking and verification by the issuer company may impact the listing of such shares.

Exchange's Right of Withdrawal

The NSE has explicitly reserved its right to withdraw the in-principle approval at a later stage if the information submitted to the exchange is found to be incomplete, incorrect, misleading, or false, or if it is in contravention of any Rules, Bye-laws, and Regulations of the Exchange, SEBI (LODR) Regulations, 2015, or guidelines and regulations issued by statutory authorities. The company has been advised that this approval does not constitute approval under any other Act, Regulation, rule, or bye-laws, and that separate approvals from concerned departments of the exchange must be sought wherever applicable. The disclosure was signed by Sonal Seth, Company Secretary and Compliance Officer, on May 09, 2026, from New Delhi.

Sat Kartar Life Limited (formerly known as Sat Kartar Shopping Limited) has filed a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, announcing the adoption of a new line of business in curated spiritual offerings and wellness-related products. The disclosure was submitted to the National Stock Exchange of India Limited on May 8, 2026, and was signed by Company Secretary & Compliance Officer Sonal Seth.

New Business Line: Scope and Activities

The new business activity covers a broad spectrum of spiritual and wellness-related operations, both in India and abroad. The company intends to engage in manufacturing, developing, marketing, trading, importing, exporting, and retailing of spiritual and wellness products, as well as offering consultation and educational services. The key areas of the proposed business are detailed below:

Parameter: Details Product Categories: Rudraksha beads, gemstones, idols, yantras, incense sticks, puja items, meditation accessories, spiritual and astrology books, audio and video content, and related items Services: Astrology consultation, online/offline spiritual education, meditation programs, healing sessions via digital platforms and physical centers Collaborations: Spiritual teachers, healers, coaches, and practitioners from various traditions Publishing: Books, journals, digital content, and audiovisual material on spirituality, consciousness, mindfulness, astrology, and personal transformation Estimated Investment: To be determined based on project feasibility and market conditions

Strategic Rationale and Expected Benefits

The company has outlined several expected benefits from this new business direction. The proposed activity is stated to align with Sat Kartar Life Limited's existing wellness-focused customer ecosystem and is expected to leverage the company's digital reach, customer engagement capabilities, and distribution infrastructure.

Key benefits highlighted in the disclosure include:

Holistic Wellness Platform: The combination of Ayurveda with spiritual products, consultations, meditation programs, and wellness content is expected to create a holistic wellness platform, enhancing the overall value proposition to customers seeking physical, mental, and spiritual well-being.

Curated and Credible Offerings: The ability to partner with teachers, healers, and experts from different traditions is expected to enable unique, curated spiritual offerings, enhancing credibility and allowing entry into international markets with culturally diverse products and services.

Revenue and Market Positioning: The new business activity is expected to contribute to revenue growth, operational synergies, and improved market positioning over the medium to long term.

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015, as amended, and in accordance with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, and SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The filing was submitted from New Delhi and acknowledged by the company's compliance officer.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.